Johanna Mercier
Vermogen: 18 M $ op 31-05-2026
Vermogen: 18 M $ op 31-05-2026
Mevrouw Johanna Mercier is Chief Commercial Officer bij Gilead Sciences, Inc. en lid van World 50, Inc. Zij is lid van de Raad van Bestuur van Neurocrine Biosciences, Inc., Leonard D Schaeffer Center For Health Policy & Economics en Robert Wood Johnson University Hospital, Inc. Mevrouw Mercier was voorheen werkzaam als President-VS Commercial bij Bristol Myers Squibb Co. Zij behaalde haar doctorale graad aan de Universiteit van Montral en een MBA aan de Concordia Universiteit.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2026 | 124.234 ( 0,01% ) | 17 M $ | 31-05-2026 | |
| 27-05-2026 | 6.853 ( 0,01% ) | 1 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-07-2019 |
| NEUROCRINE BIOSCIENCES, INC. | Directeur/Bestuurslid | 15-04-2021 |
| ARCUS BIOSCIENCES, INC. | Directeur/Bestuurslid | 29-01-2024 |
Robert Wood Johnson University Hospital, Inc.
Robert Wood Johnson University Hospital, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Bestuurslid | - |
Leonard D Schaeffer Center For Health Policy & Economics
Leonard D Schaeffer Center For Health Policy & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Bestuurslid | - |
World 50, Inc.
World 50, Inc. Internet Software/ServicesTechnology Services Operates as a peer-to-peer platform for business leaders | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-06-2019 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson University Hospital, Inc.
Robert Wood Johnson University Hospital, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
World 50, Inc.
World 50, Inc. Internet Software/ServicesTechnology Services Operates as a peer-to-peer platform for business leaders | Technology Services |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Leonard D Schaeffer Center For Health Policy & Economics
Leonard D Schaeffer Center For Health Policy & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau